Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26377597

Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2015 Dec 24
First author
Forero-Torres A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2015 Dec 24;126(26):2768-9. doi: 10.1182/blood-2015-10-671388.
    note
    Source null
    related pmid
    26705337
    relationship
    Comment in

Authors and identifiers

  1. name
    Forero-Torres A
    type
    Author
  2. name
    Holkova B
    type
    Author
  3. name
    Goldschmidt J
    type
    Author
  4. name
    Chen R
    type
    Author
  5. name
    Olsen G
    type
    Author
  6. name
    Boccia RV
    type
    Author
  7. name
    Bordoni RE
    type
    Author
  8. name
    Friedberg JW
    type
    Author
  9. name
    Sharman JP
    type
    Author
  10. name
    Palanca-Wessels MC
    type
    Author
  11. name
    Wang Y
    type
    Author
  12. name
    Yasenchak CA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Forero-Torres A
    type
    Author
  2. name
    Holkova B
    type
    Author
  3. name
    Goldschmidt J
    type
    Author
  4. name
    Chen R
    type
    Author
  5. name
    Olsen G
    type
    Author
  6. name
    Boccia RV
    type
    Author
  7. name
    Bordoni RE
    type
    Author
  8. name
    Friedberg JW
    type
    Author
  9. name
    Sharman JP
    type
    Author
  10. name
    Palanca-Wessels MC
    type
    Author
  11. name
    Wang Y
    type
    Author
  12. name
    Yasenchak CA
    type
    Author
bibliography ids
  1. nci-bib-17cc84a3614ed9a8ffbc8bea
book metadata
content sha256
613697c76d7531a593d5176727bcd9394f810b6b6fa270bb7344ce5c12fa23ca
document type
citation
dois
  1. 10.1182/blood-2015-06-644336
electronic publication date
display
2015 Sep 16
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:26377597
immutable id
pubmed:26377597@613697c76d7531a593d5176727bcd9394f810b6b6fa270bb7344ce5c12fa23ca
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
26
name
Blood
nlm unique id
7603509
pages
2798-804
volume
126
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2015 Dec 24;126(26):2768-9. doi: 10.1182/blood-2015-10-671388.
    note
    Source null
    related pmid
    26705337
    relationship
    Comment in
outcomes validated
false
pmid
26377597
provenance
batch id
4c1ece5bfc3d8e2be622
provider
NCBI PubMed ESummary
record sha256
182e332b7043f1810245208faf3571d8c8204cfcbc49ecd605ca41421ed384c4
response sha256
85f81bf7b60c457e4b5806b47c7c67c745ada2ae114069aa45de5ef977770dba
retrieved at
2026-09-09T23:47:12.730551+00:00
publication date
display
2015 Dec 24
precision
day
year
2015
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Research Support, N.I.H., Extramural
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26377597/
title
Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older.

Preserved source evidence · Not medical advice